[Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis]

Javier Martín-de-Carpi1, Santiago Jiménez Treviño2, Gemma Pujol Muncunill1

  • 1Unidad para el Cuidado Integral de la Enfermedad Inflamatoria Intestinal Pediátrica (UCIEII-P), Servicio de Gastroenterología, Hepatología y Nutrición Pediátrica, Hospital Sant Joan de Déu, Barcelona, España.

Anales De Pediatria
|December 30, 2019
PubMed

Insights

Diagnosing pediatric inflammatory bowel disease (IBD) in Spain is crucial for reducing complications. This review offers strategies to shorten the diagnostic timeline for better patient outcomes.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research

Background:

  • Pediatric inflammatory bowel disease (IBD) is uncommon in Spain.
  • Disease onset can be asymptomatic, delaying diagnosis.
  • Early diagnosis of pediatric IBD is vital for preventing complications and improving prognosis.

Purpose of the Study:

  • To provide tools and strategies to reduce the diagnostic delay in pediatric inflammatory bowel disease.
  • To analyze the intervals of time to diagnosis in pediatric IBD.
  • To identify peculiarities and conditions contributing to diagnostic delays.

Main Methods:

  • Literature review on diagnostic intervals and delays in pediatric IBD.
  • Analysis of factors influencing the time to diagnosis.
  • Synthesis of strategies to expedite diagnosis.

Main Results:

  • Diagnostic delay in pediatric IBD is a significant concern.
  • Understanding temporal intervals aids in identifying bottlenecks.
  • Specific conditions and patient factors contribute to delayed diagnosis.

Conclusions:

  • Implementing targeted tools can significantly shorten the diagnostic timeline for pediatric IBD.
  • Reducing diagnostic delay is essential for mitigating long-term sequelae.
  • Proactive strategies are needed to improve early detection and management of pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
576
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
873
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
801
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
703
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
680
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
683